DRG:HYBRiD-XL® - A Fully Automated Analyzer for Immunoassay and Clinical Chemistry

We’ve had an excellent run with the DRG Hybrid XL in our lab space. The platform is compact, the interface is concise, the assays are robust, and the results are precise. Coming from a CLIA laboratory, I’ve had the opportunity to handle a number of tabletop and full-size chemistry analyzers. Put simply, the Hybrid is among the best.

– Julian O. Yerkes Biomarkers Lab, Emory University.

The DRG: HYBRiD-XL ®: The Unique, Fully-Automated, Continuous Access Analyzer
is Now Available!

Using innovative and unique technology the DRG HYBRiD-XL ® allows, for the first time, the simultaneous measurement of immunoassays and clinical chemistry parameters, including turbidimetric tests in one sample.

The lab top analyzer is ideal for medium-sized and small laboratories, clinics, and large medical practice facilities.

Up to 40 tests of different types or 40 times of the same test, or up to 20-patient samples can be ordered by the medical practitioner over a wide range of pre-packaged tests to serve different specialties.

DRG:HYBRiD-XL Specifications



Color Monitor, Touchscreen (8.5 inch.)
Smart user guidance
Bi-directional Interface (ASTM)


Barcoded Master Curve
2 point recalibration
Long Stability

Test Principle

Enzyme Immunoassays
Clinical Chemistry



Up to 20 samples/run (12 primary tubes or 20 secondary tubes)
Random access possible
STAT possible
Reagents on board (cartridge ready to use)
Barcoded reading of samples and reagents
Serum, Plasma, Urine or Saliva samples
Sample dilution up to 1:1000



First results after 10 minutes
Up to 80 tests/hour (2 runs)
Long walk away times
Short hands-on times
Benchtop Analyzer (60,8 x 63,5 x 58,6 cm high)
Only 2 system-reagents (Wash/Needle cleaning)
Clot detection
Liquid level detection
Variable assay-sizes (24, 60, 120 tests)

Fully Automated Continuous Access Analyzer for the Simultaneous Measurement of Immunoassays and Clinical Chemistry

News and Updates

DRG:HYBRiD-XL® Summer Workshop Recap

  On June 4th-6th, the DRG:HYBRiD-XL Summer workshop took place in Germany with distributors from Nepal, Lebanon, and Australia. It was a very enthusiastic group! Key topics discussed included real situations in the field and Hepcidin as a new biomarker. Attendees...

read more

Sign Up for Our Newsletter

  • By submitting this form, you are granting: DRG International, Inc., 841 Mountain Avenue, Springfield, NJ, 07081, permission to email you. You may unsubscribe via the link found at the bottom of every email. (See our Email Privacy Policy (http://constantcontact.com/legal/privacy-statement) for details.) Emails are serviced by Constant Contact.

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.